Medical Information
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

ZIRABEV Principal Display Panel (bevacizumab-bvzr)

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

NDC 0069-0315-01
Rx only

Zirabev™
(bevacizumab–bvzr)
Injection

100 mg/4 mL
(25 mg/mL)

For Intravenous Infusion
After Dilution
One SINGLE-DOSE VIAL
DISCARD UNUSED PORTION.

PRINCIPAL DISPLAY PANEL - 4 mL Vial Label

PRINCIPAL DISPLAY PANEL - 4 mL Vial Carton

NDC 0069-0315-01

Zirabev™
(bevacizumab–bvzr)
Injection

100 mg/4 mL
(25 mg/mL)

For Intravenous Infusion
After Dilution

One SINGLE-DOSE VIAL

DISCARD UNUSED PORTION.

Rx only

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 4 mL Vial Carton

PRINCIPAL DISPLAY PANEL - 16 mL Vial Label

NDC 0069-0342-01
Rx only

Zirabev™
(bevacizumab–bvzr)
Injection

400 mg/16 mL
(25 mg/mL)

For Intravenous Infusion
After Dilution
One SINGLE-DOSE VIAL
DISCARD UNUSED PORTION.

PRINCIPAL DISPLAY PANEL - 16 mL Vial Label

PRINCIPAL DISPLAY PANEL - 16 mL Vial Carton

NDC 0069-0342-01

Zirabev™
(bevacizumab–bvzr)
Injection

400 mg/16 mL
(25 mg/mL)

For Intravenous Infusion
After Dilution

One SINGLE-DOSE VIAL

DISCARD UNUSED PORTION.

Rx only

Pfizer Biosimilars

PRINCIPAL DISPLAY PANEL - 16 mL Vial Carton
Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event